Article Details

PhaseBio Reversal Agent Continues to Show Promise in Phase III | BioSpace

Retrieved on: 2021-11-15 16:50:01

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Reversal Agent Continues to Show Promise in Phase III | BioSpace. View article details on hiswai:

Excerpt

... the antiplatelet effects of AstraZeneca's blood-thinner Brilinta. ... which had been in development by AstraZeneca as a complementary drug for ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up